FTNT vs SPRY · P/E 56, rev $6.80B vs rev $89.1M
Fortinet Inc (FTNT) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the FTNT and SPRY stock pages for the full models.
Not investment advice.